
Frequent adverse reactions at injection site have been reported during clinical trials (pain and burning sensation).
Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions.
View ADR Reporting Link